These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6112762)

  • 1. Influence of adrenergic nervous system on vasodilator-induced renin release in the conscious rat.
    Sinaiko AR
    Proc Soc Exp Biol Med; 1981 May; 167(1):25-9. PubMed ID: 6112762
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release.
    Sinaiko AR
    Life Sci; 1983 Dec; 33(23):2269-75. PubMed ID: 6316059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat.
    Pettinger WA; Campbell WB; Keeton K
    Circ Res; 1973 Jul; 33(1):82-6. PubMed ID: 4765702
    [No Abstract]   [Full Text] [Related]  

  • 4. Participation of prostaglandin and adrenergic nervous system in renin release induced by changes in renal arterial pressure in rats.
    Imagawa J; Miyauchi T; Satoh S
    Ren Physiol; 1985; 8(3):140-9. PubMed ID: 3895329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
    Boucher M; Dubray C; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.
    Keeton TK; Pettinger WA; Campbell WB
    Circ Res; 1976 Jun; 38(6):531-9. PubMed ID: 1269103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hydralazine-induced renin release by indomethacin in the rat.
    Campbell WB; Graham RM; Jackson EK
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):315-23. PubMed ID: 7002082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release.
    Saruta T; Eguchi T; Nakamura R; Misumi J; Kondo K; Oka M
    Jpn Heart J; 1980 Jan; 21(1):103-9. PubMed ID: 6102616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of caffeine on renal renin secretion and norepinephrine spillover.
    Tofovic SP; Kusaka H; Pfeifer CA; Jackson EK
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):302-13. PubMed ID: 8856488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive agents.
    Wilhelm M; DeStevens G
    Prog Drug Res; 1976; 20():197-259. PubMed ID: 13458
    [No Abstract]   [Full Text] [Related]  

  • 19. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.